Mirikizumab in patients with ulcerative colitis – a prospective national multicenter registry
-
Enrollment
This study is currently enrolling. -
Associated Conditions
-
Research Area
Digestive Health and Surgery -
Location
-
Principal Investigator
Jennifer Seminerio-Diehl -
Sponsor
University of North Carolina
The purpose of this research study is to evaluate the efficacy of mirikizumab (Omvoh) in patients with ulcerative colitis who are receiving it in a standard of care setting.
Enrollment Form
This study is currently enrolling.